Back

Speaker "Aneema Rawat" Details Back

 

Topic

IoT and Healthcare – Designing a New System to Predict Adverse Reactions

Abstract

IoT and Healthcare – Designing a New System to Predict Adverse Reactions

Profile

Aneema is Director of Business and Corporate Development at NTT Innovation Institute Inc. (NTT i3), the prestigious Silicon Valley-based innovation center for NTT Group, one of the world’s largest ICT companies. She is responsible for driving innovation initiatives to create the next generation of platforms as well as commercialization efforts for internally incubated technologies. NTT i3’s mandate is to accelerate the movement of innovation from initial idea to marketplace implementation, combining access to NTT Group’s significant global infrastructure resources, investment fund, research knowledge, and trusted long-standing customer relationships with its own software startup expertise and deep enterprise relationships. In the last 15 years, Aneema has been associated with the technology industry as a software engineer, a tech banker, a corp dev deal maker and a venture investor. Prior to NTT i3, Aneema held corporate development and investment roles at SK Telecom Americas, Hewlett Packard Enterprise and Accelerated Global Technology Corp, a tech-focused PE firm. Previously, as an investment banker with Goldman Sachs, she advised on tech M&A deals in San Francisco. Aneema started her professional career as a software engineer at Cisco Systems, working on Cisco’s early enterprise VOIP system. Aneema has an MBA from The Wharton School and MS in Computer Science from Texas A&M University.